Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (101-110 of 280) with videos related to

Pageof 28
Sort By:
European Urology Open Science|March 30, 2026
Familial Risks in 317 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding DiagnosticsKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
The Journal of Gene Medicine|March 15, 2008
The cyclo-oxygenase 2 promoter is induced in nontarget cells following adenovirus infection, but an AU-rich 3'-untranslated region destabilization element can increase specificityMerja Särkioja, Tanja Hakkarainen, Minna Eriksson, et al.
Cancers|September 28, 2024
Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway, and SwedenKari Hemminki, Frantisek Zitricky, Asta Försti, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Radiation-induced upregulation of gene expression from adenoviral vectors mediated by DNA damage repair and regulationPetri Nokisalmi, Maria Rajecki, Sari Pesonen, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic ImmunotherapyOtto Hemminki, Minna Oksanen, Kristian Taipale, et al.
Clinical Epidemiology|October 7, 2024
Survival in Thyroid Cancer in Sweden From 1999 To 2018Frantisek Zitricky, Anni Koskinen, Kristina Sundquist, et al.
The Journal of Gene Medicine|August 12, 2009
Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cellsAnniina Koski, Maria Rajecki, Kilian Guse, et al.
Clinical Epidemiology|August 11, 2021
Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary CancersGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.
Cells|April 1, 2020
TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological SignalingCamilla Heiniö, Riikka Havunen, Joao Santos, et al.
Molecular Therapy Oncolytics|April 28, 2016
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapyLisa Farzad, Vincenzo Cerullo, Shigeki Yagyu, et al.
Pageof 28

Showing results (101-110 of 280) with videos related to

Sort By:
Pageof 28
European Urology Open Science|March 30, 2026
Familial Risks in 317 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding DiagnosticsKari Hemminki, Frantisek Zitricky, Kristina Sundquist, et al.
The Journal of Gene Medicine|March 15, 2008
The cyclo-oxygenase 2 promoter is induced in nontarget cells following adenovirus infection, but an AU-rich 3'-untranslated region destabilization element can increase specificityMerja Särkioja, Tanja Hakkarainen, Minna Eriksson, et al.
Cancers|September 28, 2024
Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway, and SwedenKari Hemminki, Frantisek Zitricky, Asta Försti, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2011
Radiation-induced upregulation of gene expression from adenoviral vectors mediated by DNA damage repair and regulationPetri Nokisalmi, Maria Rajecki, Sari Pesonen, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic ImmunotherapyOtto Hemminki, Minna Oksanen, Kristian Taipale, et al.
Clinical Epidemiology|October 7, 2024
Survival in Thyroid Cancer in Sweden From 1999 To 2018Frantisek Zitricky, Anni Koskinen, Kristina Sundquist, et al.
The Journal of Gene Medicine|August 12, 2009
Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cellsAnniina Koski, Maria Rajecki, Kilian Guse, et al.
Clinical Epidemiology|August 11, 2021
Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary CancersGuoqiao Zheng, Kristina Sundquist, Jan Sundquist, et al.
Cells|April 1, 2020
TNFa and IL2 Encoding Oncolytic Adenovirus Activates Pathogen and Danger-Associated Immunological SignalingCamilla Heiniö, Riikka Havunen, Joao Santos, et al.
Molecular Therapy Oncolytics|April 28, 2016
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapyLisa Farzad, Vincenzo Cerullo, Shigeki Yagyu, et al.
Pageof 28